Mercer Global Advisors’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12M Sell
20,166
-6,779
-25% -$3.38M 0.02% 452
2025
Q4
$13.1M Buy
26,945
+7,301
+37% +$3.4M 0.02% 425
2025
Q3
$8.24M Buy
19,644
+1,932
+11% +$650K 0.01% 513
2025
Q2
$5.09M Buy
17,712
+1,909
+12% +$571K 0.01% 561
2025
Q1
$4.87M Buy
15,803
+243
+2% +$83.3K 0.01% 547
2024
Q4
$5.49M Buy
15,560
+217
+1% +$79.8K 0.01% 518
2024
Q3
$5.49M Buy
15,343
+1,425
+10% +$481K 0.01% 480
2024
Q2
$4.43M Buy
13,918
+2,013
+17% +$533K 0.01% 480
2024
Q1
$2.73M Sell
11,905
-377
-3% -$85.1K 0.01% 635
2023
Q4
$2.7M Buy
12,282
+131
+1% +$30.2K 0.01% 642
2023
Q3
$2.75M Buy
12,151
+2,237
+23% +$515K 0.01% 604
2023
Q2
$2.19M Buy
9,914
+933
+10% +$207K 0.01% 705
2023
Q1
$2.01M Buy
8,981
+706
+9% +$174K 0.01% 678
2022
Q4
$2.3M Sell
8,275
-39
-0.5% -$9.85K 0.01% 656
2022
Q3
$1.74M Sell
8,314
-92
-1% -$20.6K 0.01% 661
2022
Q2
$1.98M Sell
8,406
-13
-0.2% -$2.64K 0.01% 614
2022
Q1
$1.51M Sell
8,419
-1,285
-13% -$245K 0.01% 743
2021
Q4
$2.1M Buy
9,704
+524
+6% +$103K 0.01% 605
2021
Q3
$1.69M Buy
9,180
+339
+4% +$66.8K 0.01% 667
2021
Q2
$1.59M Buy
8,841
+868
+11% +$165K 0.01% 655
2021
Q1
$1.33M Buy
7,973
+2,889
+57% +$482K 0.01% 681
2020
Q4
$772K Buy
5,084
+2,169
+74% +$285K 0.01% 702
2020
Q3
$294K Buy
2,915
+212
+8% +$23.3K ﹤0.01% 974
2020
Q2
$327K Buy
+2,703
New +$304K 0.01% 819
2020
Q1
Sell
-7,696
Closed -$678K 1252
2019
Q4
$678K Buy
7,696
+802
+12% +$70.6K 0.01% 629
2019
Q3
$549K Buy
6,894
+2,095
+44% +$169K 0.01% 658
2019
Q2
$375K Buy
4,799
+410
+9% +$38.3K 0.01% 791
2019
Q1
$515K Buy
+4,389
New +$511K 0.02% 617

Other funds holding UTHR